[1]江明洁,贺劲松△.“三因制宜”理论辨治非酒精性脂肪性肝病[J].西部中医药,2018,31(10):22-24.
 JIANG Mingjie,HE Jinsong.Differentiating and Treating Non-alcoholic Fatty Liver Disease by the Theory of “Treatment Individualized to Patient, Season and Locality”[J].Western Journal of Traditional Chinese Medicine,2018,31(10):22-24.
点击复制

“三因制宜”理论辨治非酒精性脂肪性肝病()
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
31
期数:
2018年10期
页码:
22-24
栏目:
论坛·学术观点
出版日期:
2018-10-15

文章信息/Info

Title:
Differentiating and Treating Non-alcoholic Fatty Liver Disease by the Theory of “Treatment Individualized to Patient, Season and Locality”
文章编号:
1004-6852(2018)10-0022-03
作者:
江明洁1贺劲松2△
1 广州中医药大学第四临床医学院,广东 广州 510000; 2 深圳市中医院
Author(s):
JIANG Mingjie1 HE Jinsong2△
1 The Forth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510000, China; 2 Shenzhen Municipality Hospital of Traditional Chinese Medicine
关键词:
肝病脂肪性非酒精性三因制宜中医学
Keywords:
liver disease fatty non-alcoholic treatment individualized to patient season and locality the study of TCM
分类号:
R322.4+7
文献标志码:
A
摘要:
非酒精性脂肪性肝病的中医治疗,临床上除了辨证准确外,还需基于“三因制宜”,即因时、因地、因人制宜,了解患者年龄、性别、体质、病情轻重,了解发病时令,及所处地域环境等。
Abstract:
Except accurate differentiation in clinic, TCM therapy for non-alcoholic fatty liver disease (NAFLD) should be based upon the theory of "treatment individualized to patient, season and locality", that is, treatment should be appropriate according to the season, the locality and the patients, the age, gender, constitution and the patients′ conditions should be surveyed, as well as the onset season, the region and the environment.

相似文献/References:

[1]高舒迪,扈晓宇△.中医药治疗酒精性肝病的辨病论治概况及研究述评[J].西部中医药,2013,26(02):122.
 GAO Shudi,HU Xiaoyu.Research Review and Survey of TCM in Treating Alcoholic Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(10):122.
[2]黄晶晶,潘哲,黄妮曼,等.从温病学理论论治肝病的研究进展[J].西部中医药,2014,27(02):142.
 HUANG Jingjing,PAN Zhe,HUANG Niman,et al.Study on Treatment for Liver Disease by the Theory of Febrile Disease Science[J].Western Journal of Traditional Chinese Medicine,2014,27(10):142.
[3]田旭东,孙平,李彦龙,等.甜菜碱对酒精性肝病大鼠肝细胞色素P450 2E1基因和蛋白表达的影响*[J].西部中医药,2014,27(07):8.
 TIAN Xudong,SUN Ping,LI Yanlong,et al.Therapeutic Effects of Betaine on the Expressions of Hepatocyte Cytochrome P450 2E1 Gene and Protein of Rats with Alcoholic Liver Disease[J].Western Journal of Traditional Chinese Medicine,2014,27(10):8.
[4]陈芳玉,张杰,毛莲香,等.疏肝健脾化痰汤治疗非酒精性脂肪性肝炎50例[J].西部中医药,2015,28(06):94.[doi:2015/6/16 0:00:00]
[5]邓恺伦.疏肝降脂汤治疗肝郁脾虚型非酒精性脂肪肝44例[J].西部中医药,2020,33(04):96.[doi:10.12174/j.issn.1004-6852.2020.04.29]
 DENG Kailun.Liver-soothing Lipid-lowering Decoction in Treating 44 Cases of Nonalcoholic Steatohepatitis of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2020,33(10):96.[doi:10.12174/j.issn.1004-6852.2020.04.29]
[6]黄俊敏,曹安民,刘俊兰,等.山楂降脂丸合耳穴压豆法治疗脂肪性肝病超声图像变化比较[J].西部中医药,2013,26(11):127.
 HUANG Junmin,CAO Anmin,LIU Junlan,et al.Sonographic Changes of ShanZha JiangZhiWan and Ear Acupoint Bean-pressing Method in Treating Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(10):127.
[7]罗媛媛,张斌,蔡启茂.加味甘露消毒饮治疗早期脂肪性肝病的临床研究[J].西部中医药,2014,27(01):111.
 LUO Yuanyuan,ZHANG Bin,CAI Qimao.Clinical Study on Modified GanLu XiaoDu Drink in Treating Fatty Liver Disease at Early Stage[J].Western Journal of Traditional Chinese Medicine,2014,27(10):111.

备注/Memo

备注/Memo:
收稿日期:2018-02-12 *基金项目:广东省深圳市科技计划项目(编号20160428175 717223)。 作者简介:江明洁(1993—),女,在读硕士研究生。研究方向:中医药防治慢性肝病。 △通讯作者:贺劲松(1972—),男,博士研究生导师,博士学位,教授,主任医师。研究方向:中医药防治慢性肝病。
更新日期/Last Update: 2018-08-15